Hepatitis C Virus–Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens-Reference-Cited by-同舟云学术

Hepatitis C Virus–Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens

Published:2017-12-26 Issue:7 Volume:217 Page:1033-1043
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Stepanova Maria¹,Thompson Alexander²,Doyle Joseph³⁴,Younossi Issah¹,de Avila Leyla⁵,Younossi Zobair M⁶⁵

Affiliation:

1. Center for Outcomes Research in Liver Diseases, Washington, D. C

2. Department of Gastroenterology, St. Vincent’s Hospital

3. Department of Infectious Diseases, Alfred Hospital, Monash University

4. Burnet Institute, Melbourne, Australia

5. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia

6. Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/7/1033/24326473/jix681.pdf

Reference49 articles.

1. Global estimates of prevalence of HCV infection among injecting drug users;Aceijas;Int J Drug Policy,2007

2. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews;Nelson;Lancet,2011

3. Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus;Younossi;J Viral Hepat,2016

4. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden;Younossi;Gastroenterology,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs;Value in Health;2023-06

2. Improved health‐related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable;Addiction;2023-03-16

3. Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial;Alimentary Pharmacology & Therapeutics;2022-05-10

4. Changes in Health-related Quality of Life for Hepatitis C Virus–Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response;Clinical Infectious Diseases;2021-07-31

5. Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir;Infectious Diseases and Therapy;2021-06-14